Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study.

The Canadian journal of hospital pharmacy

Dillon C, Peddle J, Twells L, Lester K, Midodzi W, Manning K, Murphy R, Pace D, Smith C, Boone D, Gregory D.
PMID: 25964682
Can J Hosp Pharm. 2015 Mar-Apr;68(2):113-20. doi: 10.4212/cjhp.v68i2.1436.

BACKGROUND: Patients who have undergone bariatric surgery generally need fewer medications as they experience improvement in, or even resolution of, various medical conditions, including type 2 diabetes mellitus, hypertension, and dyslipidemia. Published data on changes in medication use after...

Cite
Dillon C, Peddle J, Twells L, et al. Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. Can J Hosp Pharm. 2015;68(2):113-20doi: 10.4212/cjhp.v68i2.1436.
Dillon, C., Peddle, J., Twells, L., Lester, K., Midodzi, W., Manning, K., Murphy, R., Pace, D., Smith, C., Boone, D., & Gregory, D. (2015). Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. The Canadian journal of hospital pharmacy, 68(2), 113-20. https://doi.org/10.4212/cjhp.v68i2.1436
Dillon, Carla, et al. "Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study." The Canadian journal of hospital pharmacy vol. 68,2 (2015): 113-20. doi: https://doi.org/10.4212/cjhp.v68i2.1436
Dillon C, Peddle J, Twells L, Lester K, Midodzi W, Manning K, Murphy R, Pace D, Smith C, Boone D, Gregory D. Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study. Can J Hosp Pharm. 2015 Mar-Apr;68(2):113-20. doi: 10.4212/cjhp.v68i2.1436. PMID: 25964682; PMCID: PMC4414072.
Copy Download .nbib Format: NLM
[Secondary prevention in acute myocardial infarction].

Acta medica portuguesa

Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG.
PMID: 11475986
Acta Med Port. 2001 Mar-Apr;14(2):149-69.

Myocardial infarction is still one of the main causes of mortality and morbidity in Western countries. The advances made in the last 30 years have made it possible to reduce mortality significantly (which is currently below two digits) as...

Cite
Ferreira R, Ferreira D, Correia MJ, et al. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001;14(2):149-69
Ferreira, R., Ferreira, D., Correia, M. J., De Sá, M. E., De Sousa, J. V., Sousa, J. V., & Tavares, M. G. (2001). Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa, 14(2), 149-69.
Ferreira, R, et al. "Prevenção secundária no enfarte agudo do miocárdio." [Secondary prevention in acute myocardial infarction]. Acta medica portuguesa vol. 14,2 (2001): 149-69.
Ferreira R, Ferreira D, Correia MJ, De Sá ME, De Sousa JV, Sousa JV, Tavares MG. Prevenção secundária no enfarte agudo do miocárdio. [Secondary prevention in acute myocardial infarction]. Acta Med Port. 2001 Mar-Apr;14(2):149-69. Portuguese. PMID: 11475986.
Copy Download .nbib Format: NLM
Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study.

Pharmacy practice

Cunico C, Picheth G, Correr CJ, Scartezini M.
PMID: 25035713
Pharm Pract (Granada). 2014 Apr;12(2):378. doi: 10.4321/s1886-36552014000200002. Epub 2014 Mar 15.

OBJECTIVE: to evaluate the relation between patient adherence and therapeutic effectiveness of hypolipidemic agents in clinical practice.METHODS: A retrospective cohort study of 417 patients using hypolipidemic drugs (simvastatin, atorvastatin) between 2003 and 2010 was performed. The population studied consists...

Cite
Cunico C, Picheth G, Correr CJ, et al. Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study. Pharm Pract (Granada). 2014;12(2):378doi: 10.4321/s1886-36552014000200002.
Cunico, C., Picheth, G., Correr, C. J., & Scartezini, M. (2014). Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study. Pharmacy practice, 12(2), 378. https://doi.org/10.4321/s1886-36552014000200002
Cunico, Cássia, et al. "Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study." Pharmacy practice vol. 12,2 (2014): 378. doi: https://doi.org/10.4321/s1886-36552014000200002
Cunico C, Picheth G, Correr CJ, Scartezini M. Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study. Pharm Pract (Granada). 2014 Apr;12(2):378. doi: 10.4321/s1886-36552014000200002. Epub 2014 Mar 15. PMID: 25035713; PMCID: PMC4100947.
Copy Download .nbib Format: NLM
A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.

Indian journal of pharmacology

Gopa B, Bhatt J, Hemavathi KG.
PMID: 22529483
Indian J Pharmacol. 2012 Mar;44(2):238-42. doi: 10.4103/0253-7613.93857.

OBJECTIVES: To evaluate the efficacy of Amla in patients with type II hyperlipidemia and compare its hypolipidemic effects with those of simvastatin.MATERIALS AND METHODS: Sixty type II hyperlipidemic patients of both sexes with plasma total cholesterol and low density...

Cite
Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44(2):238-42doi: 10.4103/0253-7613.93857.
Gopa, B., Bhatt, J., & Hemavathi, K. G. (2012). A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian journal of pharmacology, 44(2), 238-42. https://doi.org/10.4103/0253-7613.93857
Gopa, Biswas, et al. "A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin." Indian journal of pharmacology vol. 44,2 (2012): 238-42. doi: https://doi.org/10.4103/0253-7613.93857
Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012 Mar;44(2):238-42. doi: 10.4103/0253-7613.93857. PMID: 22529483; PMCID: PMC3326920.
Copy Download .nbib Format: NLM
Hypolipidemic activity of amine-borane aducts of cyclohexylamine and toluidine in rodents.

Metal-based drugs

Burnham BS, Chen SY, Sood A, Spielvogel BF, Hall IH.
PMID: 18472769
Met Based Drugs. 1995;2(4):221-32. doi: 10.1155/MBD.1995.221.

The amine-borane adducts of cyclohexylamine and toluidine were observed to be potent hypolipidemic agents in mice, I.P. and rats orally at 8 mg/kg/day lowering both serum cholesterol and triglyceride levels after 14-16 days. These compounds were able to lower...

Cite
Burnham BS, Chen SY, Sood A, et al. Hypolipidemic activity of amine-borane aducts of cyclohexylamine and toluidine in rodents. Met Based Drugs. 1995;2(4):221-32doi: 10.1155/MBD.1995.221.
Burnham, B. S., Chen, S. Y., Sood, A., Spielvogel, B. F., & Hall, I. H. (1995). Hypolipidemic activity of amine-borane aducts of cyclohexylamine and toluidine in rodents. Metal-based drugs, 2(4), 221-32. https://doi.org/10.1155/MBD.1995.221
Burnham, B S, et al. "Hypolipidemic activity of amine-borane aducts of cyclohexylamine and toluidine in rodents." Metal-based drugs vol. 2,4 (1995): 221-32. doi: https://doi.org/10.1155/MBD.1995.221
Burnham BS, Chen SY, Sood A, Spielvogel BF, Hall IH. Hypolipidemic activity of amine-borane aducts of cyclohexylamine and toluidine in rodents. Met Based Drugs. 1995;2(4):221-32. doi: 10.1155/MBD.1995.221. PMID: 18472769; PMCID: PMC2364981.
Copy Download .nbib Format: NLM
The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents.

Pharmaceutical research

Hall IH, Williams WL, Rhyne KA, Knowles M.
PMID: 24272843
Pharm Res. 1985 Sep;2(5):233-8. doi: 10.1023/A:1016368912659.

2-Furoic acid, 3-furoic acid, 3,4-furan dicarboxylic acid and furyl-acrylic acid were evaluated for hypolipidemic activity in mice and rats. 2-Furoic acid was the most potent agent of the four tested, lowering serum cholesterol levels 41 % and serum triglyceride...

Cite
Hall IH, Williams WL, Rhyne KA, et al. The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharm Res. 1985;2(5):233-8doi: 10.1023/A:1016368912659.
Hall, I. H., Williams, W. L., Rhyne, K. A., & Knowles, M. (1985). The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharmaceutical research, 2(5), 233-8. https://doi.org/10.1023/A:1016368912659
Hall, I H, et al. "The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents." Pharmaceutical research vol. 2,5 (1985): 233-8. doi: https://doi.org/10.1023/A:1016368912659
Hall IH, Williams WL, Rhyne KA, Knowles M. The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharm Res. 1985 Sep;2(5):233-8. doi: 10.1023/A:1016368912659. PMID: 24272843.
Copy Download .nbib Format: NLM
Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides.

Pharmaceutical research

Chapman JM, Wyrick SD, Maguire JH, Cocolas GH, Hall IH.
PMID: 24277360
Pharm Res. 1984 Nov;1(6):267-9. doi: 10.1023/A:1016346018962.

A number of substituted phthalimide, 1, 8-naphthalimide, succinimide and glutarimide derivatives demonstrated significant hypolipidemic activity at 20 mg/kg/ day, I.P. after 16 days dosing. The N-(n-pentyl) succinimide proved to be the most potent analogue of the new compounds, lowering...

Cite
Chapman JM, Wyrick SD, Maguire JH, et al. Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharm Res. 1984;1(6):267-9doi: 10.1023/A:1016346018962.
Chapman, J. M., Wyrick, S. D., Maguire, J. H., Cocolas, G. H., & Hall, I. H. (1984). Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharmaceutical research, 1(6), 267-9. https://doi.org/10.1023/A:1016346018962
Chapman, J M, et al. "Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides." Pharmaceutical research vol. 1,6 (1984): 267-9. doi: https://doi.org/10.1023/A:1016346018962
Chapman JM, Wyrick SD, Maguire JH, Cocolas GH, Hall IH. Hypolipidemic Agents of Phthalimide Derivatives 6. Effects of Aromatic vs. Non-Aromatic Imides. Pharm Res. 1984 Nov;1(6):267-9. doi: 10.1023/A:1016346018962. PMID: 24277360.
Copy Download .nbib Format: NLM
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.

International journal of molecular sciences

Vinci P, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Mearelli F, Biasinutto C, Fiotti N, Di Girolamo FG, Biolo G.
PMID: 34769118
Int J Mol Sci. 2021 Oct 28;22(21). doi: 10.3390/ijms222111687.

Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are the first-choice therapy for dyslipidemias and are considered the cornerstone of atherosclerotic cardiovascular disease (ASCVD) in both primary and secondary prevention. Despite the statin-therapy-mediated positive effects...

Cite
Vinci P, Panizon E, Tosoni LM, et al. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int J Mol Sci. 2021;22(21)doi: 10.3390/ijms222111687.
Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Di Girolamo, F. G., & Biolo, G. (2021). Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. International journal of molecular sciences, 22(21), . https://doi.org/10.3390/ijms222111687
Vinci, Pierandrea, et al. "Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy." International journal of molecular sciences vol. 22,21 (2021). doi: https://doi.org/10.3390/ijms222111687
Vinci P, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Mearelli F, Biasinutto C, Fiotti N, Di Girolamo FG, Biolo G. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int J Mol Sci. 2021 Oct 28;22(21). doi: 10.3390/ijms222111687. PMID: 34769118; PMCID: PMC8583847.
Copy Download .nbib Format: NLM
The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice.

Metal-based drugs

Miller MC, Sood A, Spielvogel BF, Hall IH.
PMID: 18475910
Met Based Drugs. 1999;6(6):337-44. doi: 10.1155/MBD.1999.337.

The boronated aromatic amino acids were shown to be potent hypolipidemic agents in mice lowering both serum cholesterol and triglycerides after 16 days. Selective compounds were as effective as the clinical standards. Furthermore, the compounds were effective anti-inflammatory agents...

Cite
Miller MC, Sood A, Spielvogel BF, et al. The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice. Met Based Drugs. 1999;6(6):337-44doi: 10.1155/MBD.1999.337.
Miller, M. C., Sood, A., Spielvogel, B. F., & Hall, I. H. (1999). The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice. Metal-based drugs, 6(6), 337-44. https://doi.org/10.1155/MBD.1999.337
Miller, M C, et al. "The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice." Metal-based drugs vol. 6,6 (1999): 337-44. doi: https://doi.org/10.1155/MBD.1999.337
Miller MC, Sood A, Spielvogel BF, Hall IH. The Hypolipidemic and Anti-Inflammatory Activity of Boronated Aromatic Amino Acids in CF(1) Male Mice. Met Based Drugs. 1999;6(6):337-44. doi: 10.1155/MBD.1999.337. PMID: 18475910; PMCID: PMC2365189.
Copy Download .nbib Format: NLM
The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats.

Metal-based drugs

Hall IH, Chen SY, Barnes BJ, West DX.
PMID: 18472903
Met Based Drugs. 1999;6(3):143-7. doi: 10.1155/MBD.1999.143.

Heterocyclic thiosemicarbazones, thioureas and their copper, nickel, and cobalt complexes were shown to be potent hypolipidemic agents in male Sprague Dawley rats at 8 mg/kg/day, orally. These agents lowered the activity of rat hepatic rate limiting enzymes for the...

Cite
Hall IH, Chen SY, Barnes BJ, et al. The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats. Met Based Drugs. 1999;6(3):143-7doi: 10.1155/MBD.1999.143.
Hall, I. H., Chen, S. Y., Barnes, B. J., & West, D. X. (1999). The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats. Metal-based drugs, 6(3), 143-7. https://doi.org/10.1155/MBD.1999.143
Hall, I H, et al. "The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats." Metal-based drugs vol. 6,3 (1999): 143-7. doi: https://doi.org/10.1155/MBD.1999.143
Hall IH, Chen SY, Barnes BJ, West DX. The hypolipidemic activity of heterocyclic thiosemicarbazones, thioureas and their metal complexes in sprague dawley male rats. Met Based Drugs. 1999;6(3):143-7. doi: 10.1155/MBD.1999.143. PMID: 18472903; PMCID: PMC2366827.
Copy Download .nbib Format: NLM
Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Journal of obesity

Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK.
PMID: 21403826
J Obes. 2011;2011:490650. doi: 10.1155/2011/490650. Epub 2011 Feb 15.

Adipose tissue metabolism is closely linked to insulin resistance, and differential fat distributions are associated with disorders like hypertension, diabetes, and cardiovascular disease. Adipose tissues vary in their impact on metabolic risk due to diverse gene expression profiles, leading...

Cite
Bjørndal B, Burri L, Staalesen V, et al. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650doi: 10.1155/2011/490650.
Bjørndal, B., Burri, L., Staalesen, V., Skorve, J., & Berge, R. K. (2011). Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. Journal of obesity, 2011490650. https://doi.org/10.1155/2011/490650
Bjørndal, Bodil, et al. "Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents." Journal of obesity vol. 2011 (2011): 490650. doi: https://doi.org/10.1155/2011/490650
Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011;2011:490650. doi: 10.1155/2011/490650. Epub 2011 Feb 15. PMID: 21403826; PMCID: PMC3042633.
Copy Download .nbib Format: NLM
Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review.

JMIR research protocols

Mozetic V, Freitas CG, Riera R.
PMID: 28228373
JMIR Res Protoc. 2017 Feb 22;6(2):e30. doi: 10.2196/resprot.6650.

BACKGROUND: Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus, and more than 75% of patients who have had diabetes for more than 20 years will have some degree of DR. This disease is highly destructive to...

Cite
Mozetic V, Freitas CG, Riera R. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR Res Protoc. 2017;6(2):e30doi: 10.2196/resprot.6650.
Mozetic, V., Freitas, C. G., & Riera, R. (2017). Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR research protocols, 6(2), e30. https://doi.org/10.2196/resprot.6650
Mozetic, Vania, et al. "Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review." JMIR research protocols vol. 6,2 (2017): e30. doi: https://doi.org/10.2196/resprot.6650
Mozetic V, Freitas CG, Riera R. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. JMIR Res Protoc. 2017 Feb 22;6(2):e30. doi: 10.2196/resprot.6650. PMID: 28228373; PMCID: PMC5343211.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries